Jupiter Topco LLC Takes Position in Ventas, Inc. $VTR

Jupiter Topco LLC purchased a new position in shares of Ventas, Inc. (NYSE:VTR) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,140,949 shares of the real estate investment trust’s stock, valued at approximately $101,300,000.

A number of other institutional investors have also added to or reduced their stakes in VTR. BlackRock Inc. purchased a new stake in Ventas in the 2nd quarter valued at about $4,953,439,000. Capital World Investors purchased a new position in shares of Ventas in the 4th quarter worth approximately $594,116,000. Norges Bank bought a new position in shares of Ventas in the fourth quarter valued at approximately $474,571,000. Legal & General Group Plc bought a new position in shares of Ventas in the second quarter valued at approximately $501,850,000. Finally, Deutsche Bank AG purchased a new stake in shares of Ventas during the second quarter valued at approximately $451,822,000. 94.18% of the stock is owned by institutional investors.

Analysts Set New Price Targets

VTR has been the topic of a number of recent analyst reports. Royal Bank Of Canada lifted their price target on Ventas from $98.00 to $99.00 and gave the stock an “outperform” rating in a report on Friday, August 14th. Evercore reaffirmed an “outperform” rating and set a $95.00 target price on shares of Ventas in a research report on Wednesday, April 29th. Jefferies Financial Group lifted their target price on Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, May 12th. JPMorgan Chase & Co. boosted their price target on shares of Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Monday, May 11th. Finally, Barclays began coverage on shares of Ventas in a report on Tuesday, July 7th. They set an “equal weight” rating and a $99.00 price objective for the company. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Ventas currently has a consensus rating of “Moderate Buy” and an average price target of $98.00.

Ventas Price Performance

Shares of NYSE VTR opened at $93.73 on Thursday. The stock has a fifty day simple moving average of $91.99 and a two-hundred day simple moving average of $87.47. Ventas, Inc. has a 1-year low of $66.38 and a 1-year high of $101.60. The firm has a market cap of $48.08 billion, a price-to-earnings ratio of 173.57, a price-to-earnings-growth ratio of 2.16 and a beta of 0.69. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86.

Ventas (NYSE:VTR) last issued its earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.01. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The firm had revenue of $1.73 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the previous year, the company posted $0.87 earnings per share. The business’s revenue was up 21.7% on a year-over-year basis. Analysts anticipate that Ventas, Inc. will post 3.89 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Michael J. Embler acquired 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was bought at an average price of $78.81 per share, with a total value of $197,025.00. Following the acquisition, the director owned 19,202 shares in the company, valued at $1,513,309.62. The trade was a 14.97% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.53% of the company’s stock.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.